← Leaderboards
Dana P Ascherman
University Of Pittsburgh At Pittsburgh
$3,212,537
Attributed
$3,540,213
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $409.6K · FY2005–24$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$3,540,213 · 4
VA$0 · 1
By mechanism
R01$2,564,245 · 2
K08$602,222 · 1
R21$373,746 · 1
I01$0 · 1
Top collaborators
- Robyn Therese Domsic3 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Robyn Therese Domsic$4,058,832
- Rohit Aggarwal$615,033
Others in their field
Top investigators on “Insight”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- James Dennis Neaton · Northwestern University$283,212,546
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$278,513,775
- Chanza Baytop · Westat, Inc.$271,217,917
- Richard K. Wilson · Washington University$200,435,757
Research focus
InsightCytokineAutoimmunityTissuesBaseAntigensImmuneMediatingAutoantigensIdiopathic Inflammatory MyopathiesOrganAutoantibodiesProteinsInflammationResponseMorbidity - Disease RateAutoimmune DiseasesInflammatoryPathogenesisTherapeutic TargetLinkCellsMyositisMuscle
Grant awards (20)
Evaluating Clinical and Immunological Consequences of SARS-CoV-2 Vaccination in Rheumatic Disease$237,514
R01 · FY2024 · AR
Evaluating Clinical and Immunological Consequences of SARS-CoV-2 Vaccination in Rheumatic Disease$209,880
R01 · FY2023 · AR
Evaluating Clinical and Immunological Consequences of SARS-CoV-2 Vaccination in Rheumatic Disease$207,958
R01 · FY2022 · AR
Innate Immune Activation in Autoimmune Myopathy$368,836
R01 · FY2021 · AR · contact PI
Innate Immune Activation in Autoimmune Myopathy$393,868
R01 · FY2020 · AR · contact PI
Innate Immune Activation in Autoimmune Myopathy$409,634
R01 · FY2019 · AR · contact PI
Innate Immune Activation in Autoimmune Myopathy$356,528
R01 · FY2018 · AR · contact PI
Innate Immune Activation in Autoimmune Myopathy$380,027
R01 · FY2017 · AR · contact PI
Peripheral Blood Biomarkers of RA-associated Interstitial Lung Disease$0
I01 · FY2014 · VA · contact PI
Peripheral Blood Biomarkers of RA-associated Interstitial Lung Disease$0
I01 · FY2013 · VA · contact PI
Peripheral Blood Biomarkers of RA-associated Interstitial Lung Disease$0
I01 · FY2012 · VA · contact PI
Peripheral Blood Biomarkers of RA-associated Interstitial Lung Disease$0
I01 · FY2011 · VA · contact PI
Functional impact of dendritic cell phenotype in a mouse model of myositis$102,317
R21 · FY2010 · AR · contact PI
Functional impact of dendritic cell phenotype in a mouse model of myositis$66,904
R21 · FY2010 · AR · contact PI
Functional impact of dendritic cell phenotype in a mouse model of myositis$204,525
R21 · FY2009 · AR · contact PI
Jo-1-specific T Cell Responses in Polymyositis$120,582
K08 · FY2007 · AR · contact PI
Jo-1-specific T Cell Responses in Polymyositis$120,582
K08 · FY2006 · AR · contact PI
Jo-1-specific T Cell Responses in Polymyositis$120,582
K08 · FY2005 · AR
Jo-1-specific T Cell Responses in Polymyositis$120,582
K08 · FY2004 · AR
Jo-1-specific T Cell Responses in Polymyositis$119,894
K08 · FY2003 · AR